Niek de Vries Selected Research

Niek de Vries Research Topics

20	Rheumatoid Arthritis 01/2022 - 04/2002
6	Immunoglobulin G4-Related Disease 08/2020 - 06/2013
5	Neoplasms (Cancer) 08/2020 - 02/2014
3	Arthritis (Polyarthritis) 09/2021 - 07/2009
3	Inflammation (Inflammations) 01/2019 - 11/2017
3	Cholangitis 01/2016 - 06/2013
2	Sclerosing Cholangitis 08/2020 - 01/2016
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019 - 06/2011
2	Immune System Diseases (Immune Disorders) 01/2017 - 12/2012
2	Autoimmune Diseases (Autoimmune Disease) 01/2015 - 06/2011
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2012 - 06/2011
1	Reinfection 01/2020
1	Mesothelioma 01/2020
1	Rheumatic Diseases (Rheumatism) 10/2019
1	Autoimmune Pancreatitis 01/2016
1	X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency) 07/2013
1	Tuberculosis (Tuberculoses) 07/2013
1	Spondylarthritis (Spinal Arthritis) 07/2009
1	Disease Susceptibility (Diathesis) 04/2002

5	AutoantibodiesIBA 01/2022 - 10/2008
5	HLA-DRB1 Chains (HLA DRB1)IBA 01/2016 - 04/2002
4	EpitopesIBA 09/2021 - 04/2002
4	Pharmaceutical PreparationsIBA 01/2019 - 08/2013
3	CytokinesIBA 01/2022 - 07/2013
3	Immunoglobulin G (IgG)IBA 08/2020 - 01/2015
3	RNA (Ribonucleic Acid)IBA 08/2020 - 07/2009
3	Anti-Citrullinated Protein AntibodiesIBA 01/2019 - 07/2009
3	MicroRNAs (MicroRNA)IBA 01/2018 - 06/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 07/2010
3	Immunoglobulins (Immunoglobulin)IBA 01/2017 - 06/2013
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
2	Rituximab (Mabthera)FDA Link 10/2019 - 01/2019
2	Rheumatoid FactorIBA 01/2019 - 11/2005
2	acetyl 4-aminosalicylic acidIBA 01/2019 - 07/2009
2	AntigensIBA 01/2017 - 07/2013
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2015
2	SolventsIBA 01/2015 - 01/2014
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Immunodominant EpitopesIBA 01/2020
1	Tumor Necrosis Factor InhibitorsIBA 01/2019
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	serum P-component (CIt)IBA 01/2016
1	AntibodiesIBA 01/2016
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2016
1	Collagen Type II (Type II Collagen)IBA 01/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	GasesIBA 01/2015
1	Biological ProductsIBA 02/2014
1	Etanercept (Enbrel)FDA Link 03/2013
1	Interferon Type IIBA 06/2011
1	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 04/2003